VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 116 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $96,992 | -81.3% | 12,580 | -53.7% | 0.00% | -85.7% |
| Q1 2019 | $520,000 | +103.1% | 27,190 | 0.0% | 0.01% | +75.0% |
| Q4 2018 | $256,000 | -50.2% | 27,190 | 0.0% | 0.00% | -42.9% |
| Q3 2018 | $514,000 | +81.0% | 27,190 | +86.9% | 0.01% | +75.0% |
| Q2 2018 | $284,000 | +120.2% | 14,544 | +1.0% | 0.00% | +100.0% |
| Q2 2017 | $129,000 | +79.2% | 14,394 | +163.0% | 0.00% | +100.0% |
| Q1 2017 | $72,000 | -22.6% | 5,473 | -24.7% | 0.00% | 0.0% |
| Q4 2016 | $93,000 | – | 7,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
| Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
| Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
| ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
| Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
| PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
| Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
| Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
| 361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
| Birchview Capital, LP | 30,000 | $516,000 | 0.34% |